| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6129590
[patent_doc_number] => 20020076754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Overcoming AAV vector size limitation through viral DNA hetero-dimerization'
[patent_app_type] => new
[patent_app_number] => 09/838786
[patent_app_country] => US
[patent_app_date] => 2001-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10506
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076754.pdf
[firstpage_image] =>[orig_patent_app_number] => 09838786
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/838786 | Overcoming AAV vector size limitation through viral DNA hetero-dimerization | Apr 19, 2001 | Abandoned |
Array
(
[id] => 1282891
[patent_doc_number] => 06642371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-04
[patent_title] => 'Haemophilus adherence and penetration proteins'
[patent_app_type] => B2
[patent_app_number] => 09/839996
[patent_app_country] => US
[patent_app_date] => 2001-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 29
[patent_no_of_words] => 15608
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09839996
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/839996 | Haemophilus adherence and penetration proteins | Apr 19, 2001 | Issued |
| 09/807908 | Assays for ligands for nuclear receiptors | Apr 18, 2001 | Abandoned |
Array
(
[id] => 7027821
[patent_doc_number] => 20010014331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'Acellular pertussis vaccine with diphthriae-and tetanus-toxoids'
[patent_app_type] => new
[patent_app_number] => 09/827785
[patent_app_country] => US
[patent_app_date] => 2001-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 2853
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014331.pdf
[firstpage_image] =>[orig_patent_app_number] => 09827785
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/827785 | Acellular pertussis vaccine with diphthriae-and tetanus-toxoids | Apr 5, 2001 | Abandoned |
Array
(
[id] => 5936002
[patent_doc_number] => 20020061555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Method for the production of bacterial toxins'
[patent_app_type] => new
[patent_app_number] => 09/825770
[patent_app_country] => US
[patent_app_date] => 2001-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8541
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061555.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825770
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825770 | Method for the production of bacterial toxins | Apr 3, 2001 | Issued |
Array
(
[id] => 6999897
[patent_doc_number] => 20010053365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'Vaccines'
[patent_app_type] => new
[patent_app_number] => 09/819464
[patent_app_country] => US
[patent_app_date] => 2001-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11473
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053365.pdf
[firstpage_image] =>[orig_patent_app_number] => 09819464
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/819464 | Vaccines | Mar 27, 2001 | Abandoned |
Array
(
[id] => 6064363
[patent_doc_number] => 20020032307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Hepadnavirus pre-S protein fragments'
[patent_app_type] => new
[patent_app_number] => 09/818066
[patent_app_country] => US
[patent_app_date] => 2001-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 23160
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032307.pdf
[firstpage_image] =>[orig_patent_app_number] => 09818066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/818066 | Hepadnavirus pre-S protein fragments | Mar 26, 2001 | Abandoned |
| 09/743484 | Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) | Mar 25, 2001 | Abandoned |
Array
(
[id] => 6047711
[patent_doc_number] => 20020168681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Microorganisms and assays for the identification of antibiotics'
[patent_app_type] => new
[patent_app_number] => 09/813453
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17574
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813453
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813453 | Microorganisms and assays for the identification of antibiotics | Mar 19, 2001 | Issued |
Array
(
[id] => 5802545
[patent_doc_number] => 20020010317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins'
[patent_app_type] => new
[patent_app_number] => 09/809060
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19594
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010317.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809060
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809060 | Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins | Mar 15, 2001 | Abandoned |
Array
(
[id] => 7289452
[patent_doc_number] => 20040110268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'ANTI-BACTERIAL VACCINE COMPOSITIONS'
[patent_app_type] => new
[patent_app_number] => 09/809665
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20958
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110268.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809665
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809665 | Anti-bacterial vaccine compositions | Mar 14, 2001 | Issued |
Array
(
[id] => 6894203
[patent_doc_number] => 20010016569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Receptor ligands'
[patent_app_type] => new
[patent_app_number] => 09/804852
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016569.pdf
[firstpage_image] =>[orig_patent_app_number] => 09804852
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/804852 | Receptor ligands | Mar 12, 2001 | Abandoned |
Array
(
[id] => 6278567
[patent_doc_number] => 20020107212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences'
[patent_app_type] => new
[patent_app_number] => 09/802445
[patent_app_country] => US
[patent_app_date] => 2001-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14388
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107212.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802445
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802445 | Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences | Mar 8, 2001 | Abandoned |
Array
(
[id] => 6225721
[patent_doc_number] => 20020004584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'HIV immune adjuvant therapy'
[patent_app_type] => new
[patent_app_number] => 09/801980
[patent_app_country] => US
[patent_app_date] => 2001-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8724
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004584.pdf
[firstpage_image] =>[orig_patent_app_number] => 09801980
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/801980 | HIV immune adjuvant therapy | Mar 7, 2001 | Abandoned |
| 09/801563 | NIMR compositions and their methods of use | Mar 7, 2001 | Abandoned |
| 09/485099 | Preparation and use of recombinant influenza a virus m2 constructs and vaccines | Mar 1, 2001 | Abandoned |
Array
(
[id] => 1411442
[patent_doc_number] => 06528496
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Compositions treating, preventing or reducing elevated metabolic levels'
[patent_app_type] => B1
[patent_app_number] => 09/793214
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14511
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528496.pdf
[firstpage_image] =>[orig_patent_app_number] => 09793214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/793214 | Compositions treating, preventing or reducing elevated metabolic levels | Feb 25, 2001 | Issued |
Array
(
[id] => 243433
[patent_doc_number] => 07589167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'ZA loops of bromodomains'
[patent_app_type] => utility
[patent_app_number] => 09/784553
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 417324
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589167.pdf
[firstpage_image] =>[orig_patent_app_number] => 09784553
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/784553 | ZA loops of bromodomains | Feb 15, 2001 | Issued |
Array
(
[id] => 1328779
[patent_doc_number] => 06596179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-22
[patent_title] => 'Apparatus for the separation of biologic components from heterogeneous cell populations'
[patent_app_type] => B2
[patent_app_number] => 09/785949
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8320
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596179.pdf
[firstpage_image] =>[orig_patent_app_number] => 09785949
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/785949 | Apparatus for the separation of biologic components from heterogeneous cell populations | Feb 15, 2001 | Issued |
| 09/701979 | Method for staining biological specimens by combining unstable reagents on a microscope slide | Feb 11, 2001 | Abandoned |
